Related Experiment Videos
Dysfibrinogenaemia and liver cell growth
Journal of Clinical Pathology
|January 1, 1978
Summary
Dysfibrinogenemia may stem from fetal fibrinogen production by proliferating liver cells in regenerating or neoplastic tissue. Prolonged reptilase clotting time might indicate hepatocytic death, not dysfibrinogenemia.
Area of Science:
- Hematology
- Hepatology
- Biochemistry
Background:
- Dysfibrinogenemia is a condition characterized by abnormal fibrinogen function.
- Prolonged reptilase clotting time has been traditionally associated with dysfibrinogenemia.
Purpose of the Study:
- To investigate the underlying mechanisms of dysfibrinogenemia.
- To re-evaluate the diagnostic significance of prolonged reptilase clotting time.
Main Methods:
- Analysis of fibrinogen production in regenerating and neoplastic liver tissues.
- Correlation of reptilase clotting time with liver cell viability and fibrinogen characteristics.
Main Results:
- Evidence suggests dysfibrinogenemia involves the production of normal fetal fibrinogen by rapidly proliferating liver cells.
- Prolongation of reptilase clotting time may be a consequence of hepatocytic death rather than dysfibrinogenemia itself.
Conclusions:
- Dysfibrinogenemia may be linked to fetal fibrinogen production in specific liver conditions.
- Reptilase clotting time requires careful interpretation, as it may reflect liver cell damage.